Mark James Litton serves as Executive at ALDER BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Mark James Litton has executed 66 insider transactions totaling $5.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 31, 2016 involved selling 19,720 shares valued at $592.6K.
Mark James Litton currently holds 40,828 shares of ALDER BIOPHARMACEUTICALS INC (ALDR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark James Litton has been a net seller of ALDR stock. They have purchased $0 and sold $5.6M worth of shares.
Mark James Litton's most recent insider trade was on May 31, 2016, when they sold 19,720 shares at $30.05 per share.
Get notified when new Form 4 filings are submitted
| $30.06 |
| Discretionary |
| May 27, 2016 | ALDR | $2.1K | Option Exercise | 5,280 | $0.39 | Discretionary |
| Jan 4, 2016 | ALDR | $245.6K | Sale | 7,709 | $31.86 | Discretionary |
| Jan 4, 2016 | ALDR | $539.3K | Sale | 17,291 | $31.19 | Discretionary |
| Jan 4, 2016 | ALDR | $9.8K | Option Exercise | 25,000 | $0.39 | Discretionary |
| Oct 1, 2015 | ALDR | $18.4K | Sale | 560 | $32.81 | Discretionary |
| Oct 1, 2015 | ALDR | $223.6K | Sale | 6,940 | $32.22 | Discretionary |
| Sep 24, 2015 | ALDR | $16.2K | Option Exercise | 12,764 | $1.27 | Discretionary |
| Jul 1, 2015 | ALDR | $383.3K | Sale | 7,500 | $51.10 | Discretionary |
| Jun 4, 2015 | ALDR | $9.8K | Option Exercise | 25,000 | $0.39 | Discretionary |
| Jun 4, 2015 | ALDR | $1.1M | Sale | 25,000 | $44.27 | Discretionary |
| Apr 1, 2015 | ALDR | $205.6K | Sale | 7,500 | $27.41 | Discretionary |
| Jan 27, 2015 | ALDR | $65.6K | Sale | 2,300 | $28.52 | Discretionary |
| Jan 26, 2015 | ALDR | $145.8K | Sale | 5,200 | $28.03 | Discretionary |
| Nov 20, 2014 | ALDR | $468.9K | Sale | 30,000 | $15.63 | Discretionary |